Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients

Clinical Pharmacokinetics

Volumn 33, Issue 5, 1997, Pages 313-327

  Anderson, Brian J ^a   McKee, Andrew D ^a   Holford, Nicholas H G ^b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUPIVACAINE; FENTANYL; INHALATION ANESTHETIC AGENT; KETAMINE; METHOXYFLURANE; MORPHINE; NITROUS OXIDE; OPIATE; REMIFENTANIL; SEVOFLURANE; TRICHLOROETHYLENE;

ANALGESIA; BODY SIZE; BODY SURFACE; BODY WEIGHT; BREATHING; CHILD; CHILD DEVELOPMENT; CONVULSION; DOSE CALCULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG UPTAKE; EPIDURAL DRUG ADMINISTRATION; HEART OUTPUT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER SIZE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 0030813117     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199733050-00001     Document Type: Review

References (117)

1. Curran WI, Beecher HK. Experimentation in children: a re-examination of legal and ethical principles. JAMA 1969; 10: 77-83
2. Shirkey H. Therapeutic orphans [editorial]. J Pediatr 1968; 72: 119-120
3. Meakin G. Role of propofol in paediatric anaesthetic practice. Paediatr Anaesth 1995; 5: 147-9
4. Ritchel WA. Handbook of basic pharmacokinetics. 2nd ed. Hamilton (IL): Drug Intelligence Publications, 1980
5. Gould SJ. Allometry and size in ontogeny and phylogeny. Bio Rev Cambridge Philosophic Soc 1966; 41: 587-640
6. Rensch B. Increase of learning capacity with increase of brain size. Am Natural 1956; 90: 81-95
7. Huxley JS. Problems of relative growth. 2nd ed. New York: Dover. 1992
8. Thompson DW. On growth and form. In: Bonner JT, editor. Cambridge: Cambridge University Press, 1961
9. Pedley TJ. Scale effects in animal locomotion. New York: Academic Press, 1977
10. Schmidt-Nielson K. Animal physiology: adaptation and environment. 2nd ed. Cambridge: Cambridge University Press, 1979
11. Kendeigh SC, Dol'nik VR, Govrilov VM. Avian energetics. In: Pinowski J, Kendeigh SC. editors. Granivorous birds in ecosystems. Cambridge: Cambridge University Press, 1977: 127-204
12. Clutton-Brock TH, Harvey PH. Species differences in feeding and ranging behaviour in primates. In: Clutten-Brock TH. editor. Primate ecology, New York: Academic Press, 1977: 557-84
13. Clutton-Brock TH, Harvey PH. Primate ecology and social organisation. J Zoo 1977; 183: 1-39
14. Peters HP. The ecological implications of body size. Cambridge: Cambridge University Press, 1983: 48-53
15. Kleiber M. The fire of life: an introduction to animal energetics. New York: Wiley, 1961
16. McMahon TA. Size and shape in biology. Science 1973; 179: 1201-4
17. McMahon TA. Scaling physiological time: lectures on mathematics in the life sciences. Lect Math Life Sci 1980; 13: 131-3
18. Paxton JW, Young D. Robertson IG. Pharmacokinetics of acridine-4-carboximade in the rat, with extrapolation to humans. Can Chemother Pharmacol 1993; 32: 323-5
19. Cruze CA, Keim GR, Meredith MR Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology. Pharm Res 1995; 12: 895-901
20. Lave T, Schmitt-Hoffmann AH, Coassolo P, et al. A new extrapolation method from animals to man: application to a metabolised compound, nefarotene. Life Sci 1995; 56: 473-8
21. Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30: 329-32
22. Prothero JW. Scaling of blood parameters in mammals. Comp Biochem Physiol 1980; A67: 649-57
23. Adolf EF. Quantitative relations in the physiological constitutions of animals. Science 1949; 109: 579-85
24. Guyton AC. Measuremrnt of the respiratory volumes of laboratory animals. Am J Physiol 1947; 150: 70-7
25. Stahl WR. Scaling of respiratory variables in mammals. J App Physiol 1967; 22: 453-60
26. Du Bois D, Du Bois EF. Clinical calorimetry. 10th paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863
27. Sheiner LB, Stanski DR, Vozeh S, et al. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358-71
28. Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modelling to analgesia. In: Foley KM, Inturrisi CE. editors. Advances in pain research and therapy: opioid analgesics in the management of clinical pain. New York: Raven Press 1986; 441-52
29. Inturrisi CE, Colburn WA, Kaiko RF, et al. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987; 41: 392-401
30. Scott JC, Stanski DR. Decreased fentanyl and alfentanil requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159-66
31. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53-63
32. Hughs MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1991; 74: 53-63
33. Aranda JV, MacLoed SM, Renton KW, et al. Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr 1974; 85: 534-42
34. Pelkonen O, Karki NT. Drug metabolism in human fetal tissues. Life Sci 1973; 13: 1163-80
35. Henderson CJ, Bammler T, Wolf CR. Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney. Biochem Biophys Acta 1994; 1200: 182-90
36. Wilson JT. Identification of STH (somatotrophin) as the hormone in a mixture of STH, ACTH and prolactin which decreased liver drug metabolism in the rat. Biochem Pharmacol 1969; 18: 2029
37. Wilson JT. Alteration of normal development of drug metabolism by injection of growth hormone. Nature 1970; 225: 861-3
38. Wilson JT, Frohman LA. Concomitant association between high plasma levels of growth hormone and low hepatic mixed-function oxidase activity in the young rat. J Pharm Exp Ther 1974; 189: 255-70
39. Buhler R, Lindros KO, Nordling A, et al. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem 1992; 204: 407-12
40. 7-methylation of theophylline to caffeine in premature infants. Dev Pharmacol Ther 1981; 2: 137-44
41. Alam SN, Roberts RJ, Fischer LJ. Age related differences in salicylamide and acetaminophen conjugation in man. J Pediatr 1977; 90: 130-5
42. West JR, Smith HW, Chasis H. Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy. J Pediatr 1948; 32: 10-8
43. Dutton GJ. Developmental aspects of drug conjugation with special reference to glucuronidation. Ann Rev Pharmacol Toxicol 1978; 18: 17-35
44. McRorie TI, Lynn AM, Nespeca MK, et al. The maturation of morphine clearance and metabolism. Am J Dis Child 1992; 146: 972-6
45. Pokela ML, Olkkola KT, Seppala T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20: 26-34
46. Stanski DR, Greenblatt DJ, Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 1978; 24: 52-9
47. Johnson KL, Erickson JP, Holley FO, et al. Fentanyl pharmacokinetics in the pediatric population (abstract). Anesthesiology 1984; 61: A441
48. Gauntlett IG, Fisher DM, Hertzka RE, et al. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988; 69: 683-7
49. Leff RD, Fischer IJ, Roberts RJ. Phenytoin metabolism following intravenous and oral administration. Dev Pharmacol Ther 1986; 9: 217-23
50. Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. II: phenytoin. carbamazepine. sulthiame. lamotrigine, vigahatrin, oxcarbazepine and felbamate. Clin Pharmacokinet 1995; 29: 341-69
51. Grasela TH, Sheiner LB, Rambeck B, et al. Steady-state pharmacokinetics of phenytoin from routinely collected patients. Clin Pharmacokinet 1985; 8: 355-64
52. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics: a preliminary appraisal. Clin Pharmacokinet 1995; 29: 80-94
53. Kaplan A, Glass PS, Jacobs JR, et al. Context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995; 83: 968-75
54. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (G187084B). Anesth Analg 1993; 77: 1031-40
55. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33
56. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-20
57. Shlugman D, Duforc S, Dershwitz M, et al. Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls [abstract]. Anesthesiology 1994; 81: A1417
58. Davis PJ, Ross A, Stiller RL, et al. Pharmacokinetics of remifentanil in anaesthetised children 2-12 years of age. Anesth Analg 1995; 80: S581
59. Rudolph AM. Changes in the circulation after birth. In: Rudolph AM, editor. Congenital diseases of the heart. Chicago: Year Book Medical Publishers, 1974: 9
60. Stahlman M, Gray J, Young WC, et al. Cardiovascular response of the neonatal lamb to hypoxia and hypercapnia. Am J Physiol 1967; 213: 899-904
61. Scott S, Lucas P, Cole T, et al. Weight gain and movement patterns of very low birthweight babies nursed on lambswool. Lancet 1983; 11(8357): 1014-6
62. Wallace JM, Aitken RP, Cheyne MA. Nutrient partitioning and fetal growth in rapidly growing adolescent ewes. J Reprod Fertil 1996; 107: 183-90
63. Metcalfe J, Parer JT. Cardiovascular changes during pregnancy in ewes. Am J Physiol 1966; 210: 821-5
64. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth Intens Care 1990; 18: 440-8
65. Stanski DR, Ham J, Miller RD, et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxidenarcotic and halothane anesthesia in man. Anesthesiology 1979; 51: 235-41
66. Prys-Roberts C, Lloyd JW, Fisher A, et al. Deliberate profound hypotension induced with halothane: studies of haemodynamics and pulmonary gas exchange. Br J Anaesth 1974; 46: 105
67. Pauca AL, Hopkins AM. Acute effects of halothane, nitrous oxide and thiopentone on upper limh blood flow. Br J Anaesth 1972; 43: 326-33
68. Salanitre E, Rackow H. The pulmonary exchange of nitrous oxide and halothane in infants and children. Anesthesiology 1969; 30: 388-94
69. Clough JB, Duncan AW, Sly PD. The effect of sustained positive-airway pressure on derived cardiac output in children. Anaesth Intens Care 1994; 22: 30-4
70. Lerman J. Pharmacology of inhalational anaesthetics in infants and children. Paediatr Anaesth 1992; 2: 191-203
71. Malviya S, Lerman J. The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and humans. Anesthesiology 1990; 72: 793-6
72. Lerman J, Schmitt BI, Willis MM, et al. Effects of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 1986; 65: 307-11
73. Nightingale DA, Richards CC, Glass A. An evaluation of rebreathing in a modified T-piece system during controlled ventilation of anaesthetised children. Br J Anaesth 1965; 37: 762
74. Bain JA, Spoerel WE. Flow requirements for a modified Mapleson D System during controlled ventilation. Can Anaesth Soc J 1973; 20: 629-36
75. Rose DK, Froese AB. The regulation of PaCO2 during controlled ventilation of children with a T-piece. Can Anaesth Soc J 1979; 26: 104-13
76. Nightingale DA, Lambert TF. Carbon dioxide output in anaesthetised children. Anaesthesia 1978; 33: 594-600
77. O'Rourke PP, Crone RK. The respiratory system. In: Gregory GA. editor. Pediatric anesthesia. 2nd ed. New York: Churchill Livingstone, 1989
78. Harrison GA. Ayre's T-piece: a review of its modifications. Br J Anaesth 1964; 36: 115
79. Ehrnebo M, Agurell S, Jalling B, et al. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Eur J Clin Pharmacol 1971; 3: 189-93
80. Kurz H, Michels H, Stickel HH. Differences in the binding of drugs to plasma proteins from newborn to adult man. II. Eur J Clin Pharmacol 1977; 11: 469-72
81. Thiessen H, Jacobsen J, Brodersen R. Displacement of albumin-bound bilirubin by fatty acids. Acta Paediatr Scand 1972; 61: 285-8
82. Holford NHG, Benet LZ. Pharmacokinetics and pharmacodynamics: rational dose selection and the time course of drug action. In: Katzung B, editor. Basic and clinical pharmacology. 6th ed. Palo Alto: Appleton and Lange, 1995: 46
83. Rowland M, Tozer TN, editors. Clinical pharmacokinetics: concepts and applications. 3rd ed. Baltimore: Williams and Wilkins, 1995
84. Berde C. Convulsions associated with pediatric regional anesthesia. Anesth Analg 1992; 75: 164-6
85. Maziot JX, Denson DO, Samii K. Pharmacokinetics of bupivacuinc following caudal anesthesia in infants. Anesthesiology 1988; 68: 387-91
86. Wilkinson GR, Lund PC. Bupivacaine levels in plasma and cerehrospinal fluid following peridural administration. Anesthesiology 1970; 33: 482-6
87. Lund PC, Bush DF, Covino BG. Determinants of etidocaine concentration in the blood. Anesthesiology 1975; 42: 497-503
88. Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet 1979; 4: 241-78
89. Hasselstrom L, Nortved-Sorensen J, Kehlet H, et al. The influence of systemically administered bupivacaine on cardiovascular function in cholecystectomised patients. Acta Anaesthesiol Scand 1985; 29 Suppl. 80: 76
90. Ecoffey C, Desparmat J, Berdeaux A, et al. Bupivacaine in children: pharmacokinetics following caudal anesthesia. Anesthesiology 1985; 63: 447-8
91. Eyres RL, Bishop W, Oppenheim RC, et al. Plasma bupivacaine concentrations in children during caudal epidural analgesia. Anaesth Intens Care 1983; 11: 20-2
92. Luz G, Innerhofer P, Fischhut B, et al. Bupivacaine plasma concentrations during continuous epidural anesthesia in infants and children. Anesth Analg 1996; 82: 231-4
93. Agarwal R, Gutlove DP, Lockhart CH. Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. Anesth Analg 1992; 75: 284-6
94. McCloskey JJ, Haun SE, Deshpande JK. Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. Anesth Analg 1992; 75: 287-90
95. Larsson BA, Lonnqvist PA, Olsson GL. Plasma concentrations of bupivacaine in neonates after epidural infusion. Anesth Analg 1997; 84: 501-5
96. Bosenberg AT, Bland BAR, Schulte Steinberg O, et al. Thoracic epidural anaesthesia via the caudal route in infants and children. Anesthesiology 1988; 69: 265
97. Tucker GT. Pharmacokinetics of local anaesthetics. Br J Anaeslh 1986; 58: 717-3
98. Baumgarten RK. Pharmacokinetic basis for local anesthetic infusions. Anesth Analg 1993; 77: 1302
99. Scott DB. Evaluation of clinical tolerance of local anestheticagents. Br J Anaesth 1975; 47: 328-33
100. Eyes RL, Kidd J, Oppenheim R, et al. Local anaesthetic plasma levels in children. Anaesth Intens Care 1978; 6: 243-7
101. British National Formulary. London: British Medical Association. 1995: 11
102. Martindale: the extra pharmacopoeia. London: The Pharmaceutical Press, 1989
103. Catzel P, Olver R. Paediatric prescriber. Oxford: Blackwell, 1981: 8-12
104. Lack JA, Stuart-Taylor ME. Calculation of drug dosage and body surface area of children. Br J Anaesth 1997; 78: 601-5
105. Reilly JJ, Workman P. Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations. Can Chemother Pharmacol 1993; 32: 411-8
106. Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 1961; 28: 169-81
107. Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age related differences and therapeutic implications. Clin Pharmacokinet 1980; 5: 485-527
108. Lockhart CH, Nelson W. The relationship of ketamine requirement to age in pediatric patients. Anesthesiology 1974; 40: 507-8
109. Grant IS, Nimmo WS, McNicol LR, et al. Kelamine disposition in children and adults. Br J Anaesth 1983; 55: 1107-11
110. Cook DR, Davis PJ. Pediatric anesthesia pharmacology. In: Lake C, editor. Pediatric cardiac anesthesia. Sydney; Prentice-Hall, 1988: 138
111. Lesley FM, Tso S, Hurlbut DE. Differential appearance of opioid receptor subtypes in neonatal rat brain. Life Sci 1982; 31: 1393-6
112. Barg J, Rius RA, Bern WT, et al. Differential development of B-endorphin and u-opioid binding sites in mouse brain. Develop Brain Res 1992; 66: 71-6
113. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965; 6: 454-61
114. Kupferberg HJ, Way EL. Pharmacologic basis for the increased sensitivity of the newborn rat to morphine. J Pharmacol Exp Ther 1963; 141: 105-12
115. Chay PC, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther 1942; 51: 334-42
116. Hertzka RE, Gauntlett IS, Fisher DM, et al. Fentanyl-induced ventilatory depression: effects of age. Anaesthesiology 1989; 70:213-8
117. Koehntop DE, Rodman JH, Brundage GM, et al. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986; 65: 227-32